Brand Recall Hub

Teva Recalls in Canada

35 recalls found for Teva. Data sourced from Health Canada, CFIA, and Transport Canada. Updated daily.

35 Teva Recalls

Other Type I
2026-08-15

Two lots of Teva-Pregabalin 150 mg capsules recalled due to cross-contamination with the drug sertraline

Contamination

View recall details →

Health Products Type II
2026-08-07

TEVA-ECTOSONE 0.1% Cream; Affected lot may be missing lot number and expiry date

Labelling

View recall details →

Health Products Type II
2026-02-18

Teva-Indomethacin: Out of specification

Product quality

View recall details →

Other
2026-01-13

Teva Octreotide for injectable suspension recalled due to potential drug quality issues

Product quality

View recall details →

Health Products Type II
2025-12-18

Teva-Topilene Ointment 0.05%: The assay is potentially out of specification in the affected lot during its shelf life.

Product quality

View recall details →

Health Products Type II
2025-06-18

Teva-Piroxicam 10 mg capsule; Out of specification (Dissolution)

Product quality

View recall details →

Health Products Type II
2025-04-07

Teva 5-ASA tablet (aka MESALAMINE): Out of Specification (Stability - Dissolution)

Product quality

View recall details →

Health Products Type II
2024-12-20

TEVA-Codeine Tablets: out of specification on friability test (broken tablet) during stability testing for affected lots.

Product safety

View recall details →

Health Products Type I
2024-12-04

TEVA-Betahistine Tablets: Affected lots exceed or may exceed the interim acceptable intake limit for N-nitroso-betahistine.

Product safety

View recall details →

Health Products Type II
2024-08-09

Recall: Teva- Bupropion 300mg - lower strength tablet

Product quality

View recall details →

Health Products Type I
2024-08-05

Expanded recall: ratio-ECTOSONE (TEVA-ECTOSONE) 0.1% regular lotion and 0.05% mild lotion recalled due to an impurity that may pose health risks

Product quality - Labelling

View recall details →

Other
2024-08-03

Expanded recall: ratio-ECTOSONE (TEVA-ECTOSONE) 0.1% regular lotion and 0.05% mild lotion recalled due to an impurity that may pose health risks

Product quality

View recall details →

Health Products Type II
2024-06-27

Teva-Topilene 0.05% Ointment: Out of Specification

Product quality

View recall details →

Health Products Type II
2024-02-07

TEVA-DILTIAZEM XC: Out of specification

Health products

View recall details →

Health Products Type III
2022-11-21

Teva-Atenolol; Product label image incorrect

Labelling

View recall details →

Health Products Type III
2022-03-02

Teva-Ectosone: product quality

Product quality

View recall details →

Health Products Type I
2021-08-26

Teva-Losartan (2021-08-26)

Product safety

View recall details →

Health Products Type I
2021-05-25

TEVA-Losartan Product Recall (2021-05-25)

Product safety

View recall details →

Health Products Type II
2021-04-06

Teva-Varenicline 0.5mg (2021-04-06)

Product safety

View recall details →

Health Products Type II
2021-04-06

Teva-Varenicline 1mg (2021-04-06)

Product safety

View recall details →

Health Products Type II
2021-04-06

Teva-Varenicline (2021-04-06)

Product safety

View recall details →

Health Products Type II
2020-08-21

Teva Canada Limited Product Recall (2020-08-21)

Product safety

View recall details →

Health Products Type III
2020-07-24

Teva-Triamterene/HCTZ (2020-07-24)

Product safety

View recall details →

Health Products Type II
2020-06-05

Teva-Carvedilol (2020-06-05)

Product safety

View recall details →

Health Products Type III
2020-06-01

Teva-Cotridin (2020-06-01)

Product safety

View recall details →

Other
2020-05-13

Important Safety Information - Importation of Teva UK-labelled Salamol CFC-Free (Salbutamol Sulfate) Inhaler due to Shortage

Product safety

View recall details →

Health Products Type III
2020-01-31

Teva-Ramipril (2020-01-31)

Product safety

View recall details →

Health Products Type I
2019-10-17

Teva Canada Ranitidine Product Recall (2019-10-17)

Product safety

View recall details →

Health Products Type III
2019-07-12

Teva Canada Products Recall (2019-07-12)

Product safety

View recall details →

Health Products Type I
2019-03-06

TEVA-LOSARTAN/HCTZ (2019-03-06)

Product safety

View recall details →

Showing 30 of 35 recalls. View all →